Health NewsFeed

Health Newsfeed

 EPCA

ANCHOR LEAD:  DETECTION OF PROSTATE CANCER MAY NOW GET BETTER WITH USE OF A NEW TEST, ELIZABETH TRACEY REPORTS

Finding prostate cancer has been hampered by lack of a reliable test to pinpoint the disease, but now Robert Getzenberg and colleagues at Johns Hopkins may have developed one.

GETZENBERG:  So we developed this new test for prostate cancer, that picks up this marker EPCA2, and we’ve done a study now which we’ve just published in 385 patients.  We’re quite confident that if the test is positive it’s almost a certainty that there’s prostate cancer there.                      :14

Getzenberg says prostate specific antigen or PSA testing has never been able to isolate cancer from other prostate conditions.

GETZENBERG:  We’ve been looking for a more specific marker for prostate cancer and what that means is we don’t want to pick up a lot of things that happen in men as they age which are, for example, BPH, a benign growth of your prostate, or prostatitis, which is an inflammation of your prostate.                        :13

Getzenberg predicts that an EPCA based test should be available clinically shortly.  I’m Elizabeth Tracey reporting.


-- JHMI --
Search Health NewsFeed

-----------------------------------------
Health NewsFeed Home | Hopkins Medicine Home